Skip to content

Few HIV infections among PrEP users in Brazil and Mexico, but challenges in Peru

Slide from Professor Carlos Cáceres's presentation to IAS 2021.

Large UK study identifies increased cardiovascular risk in people living with HIV, including younger people

Slide from Tiffany Gooden's presentation to IAS 2021.

Twice-a-year injected drug shows promise for first-line HIV treatment

Professor Samir Gupta

Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in Namibia, and a 20-percentage-point increase in Nigeria

Slide from Dr Franklin Emerenini's presentation on the Nigerian study at IAS 2021.

Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment

Khayelitsha, Cape Town, South Africa. Photographer: Rowan Pybus, Médecins Sans Frontières.

People with HIV should be prioritised for COVID-19 vaccination due to higher risk, WHO recommends

Dr Silvia Bertagnolio (centre row, right), Prof Dr Adeeba Kamarulzaman (centre row, left) and Dr Meg Doherty (bottom row, right) at an IAS 2021 press conference.

Sexual violence against women and girls in Uganda increased during the COVID-19 pandemic

Graphs from Rose Apondi's presentation

Hepatitis C virtually eliminated in people with HIV in the Netherlands

Graph showing the decline in prevalence from Dr Cas Isfordink's presentation

Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all

Graphic from the poster showing the evolution of guidelines in the 20 countries